MAPT and Alzheimer disease: For instance, we did not address the relationship between the degu Apoe Mt4 to tau pathology or microglial activation, which are both major mediators of human AD pathogenesis, nor did we test for causal influences of microbiome changes associated with the degu Apoe Mt4and human APOE4.